Features
At Spectrum Medical Imaging Co., we support healthcare facilities in delivering exceptional patient care through streamlined operations and reliable medical imaging supplies. We provide trusted access to diagnostic imaging products like GUERBET ELUCIREM 7.5ML PF 10/BX, backed by full-spectrum medical imaging services that help radiologic technologists, purchasing managers, and administrators maintain workflow efficiency and contrast media availability.
GUERBET ELUCIREM 7.5ML PF 10/BX is a high-performance gadolinium-based contrast agent delivered in a convenient pre-filled syringe format. Designed to enhance workflow efficiency and safety, it supports consistent, high-quality outcomes in MRI procedures and contrast media in radiology.
The 7.5 mL pre-filled syringes are ideal for busy imaging departments, helping maintain patient flow and schedule efficiency during every imaging exam.
The ready-to-use design minimizes prep time, ensures accurate dosing, and reduces variability in intravenous administration.
Unlike multi-dose formats, pre-filled syringes limit product waste and reduce handling risks for healthcare professionals, contributing to safer and more effective diagnostic imaging.
GUERBET ELUCIREM 7.5ML PF 10/BX is the reliable, workflow-ready solution imaging teams need to improve operational efficiency while delivering top-tier patient care.
GUERBET ELUCIREM Gadopiclenol 7.5 ML PF offers distinct clinical advantages in real-world diagnostic settings, supporting clear and confident diagnoses. As a modern gadolinium contrast agent, it plays a vital role in enhancing the visibility of representative lesions during an imaging exam.
GUERBET ELUCIREM 7.5ML PF 10/BX is a high-performance gadolinium-based contrast agent formulated to deliver precise, targeted enhancement for a wide range of magnetic resonance imaging (MRI) applications. Its clinical effectiveness has been demonstrated across multiple anatomical areas.
Approved for pediatric patients aged 2 years and older, providing flexibility for use across a wide patient population.
Enhances the detection and visualization of lesions with abnormal vascularity in the central nervous system (CNS), supporting neurologic diagnoses.
Delivers consistent enhancement for identifying vascular and soft tissue abnormalities throughout the body, aiding in comprehensive diagnostic imaging.
Proven effectiveness in real-world imaging settings, with strong performance in lesion detection across diverse medical imaging needs.
With its reliable performance and broad application, ELUCIREM 7.5ML PF contributes to accurate, efficient diagnoses and improved outcomes in modern MRI procedures.
Elucirem, a gadolinium-based contrast agent (GBCA), features high relaxivity. This characteristic provides diagnostic benefits by potentially improving lesion detectability and diagnostic clarity at lower doses compared to some other gadolinium-containing contrast agents. This high relaxivity supports effective MRI examinations and can contribute to Concordance in lesion detectability.
The GUERBET ELUCIREM 7.5ML PF 10/BX format is engineered to meet the operational demands of modern imaging departments. It enhances workflow efficiency, supports accurate dosing, and improves supply management—key priorities for teams managing medical imaging supplies.
Packaged in a 10-count box, the pre-filled format simplifies inventory tracking, reduces overuse, and supports efficient dose control, especially when compared to multi-dose vials.
The pre-filled syringe allows for quick, consistent intravenous injection, minimizing prep time and improving workflow for radiologic technologists.
By reducing handling time and administration steps, technologists can shift their focus to patient care, helping facilities maintain throughput and overall medical imaging performance.
With its time-saving design and practical packaging, GUERBET ELUCIREM 7.5ML PF 10/BX delivers measurable workflow and cost benefits for busy imaging teams.
Spectrum Medical Imaging Co. is a trusted provider of gadolinium-based contrast agents, including GUERBET ELUCIREM 7.5ML PF 10/BX. As a certified distributor with long-standing manufacturer relationships, we ensure reliable access to high-quality MRI contrast solutions.
We also provide comprehensive contrast injector repair and maintenance services to keep your imaging workflow running smoothly. Contact us to request a quote, check availability, or speak with a product specialist today.
Yes, ELUCIREM gadopiclenol injection is approved for use in both paediatric patients aged 2 years and older and elderly patients. Clinical evaluations support its safety across age groups when administered appropriately. Healthcare providers should still assess individual patient risk, especially for high-risk patients, to minimize any potential risk of complications during medical imaging procedures.
While ELUCIREM is well tolerated in most cases, some patients may experience adverse reactions such as injection site pain, injection site coldness, headache, or nausea. In rare cases, more severe reactions may occur, including allergic reactions or anaphylactic reactions. Healthcare providers should monitor all patients closely during and after administration, especially those with known sensitivities.
ELUCIREM gadopiclenol injection is a high-relaxivity contrast agent that enhances lesion visibility throughout the human body, enabling greater clarity in MRI scans. Its performance helps radiologists achieve more accurate diagnoses, particularly when used with modern medical imaging equipment for CNS, musculoskeletal, and vascular assessments.
Healthcare providers should screen for a history of hypersensitivity or renal impairment before administering ELUCIREM. Close observation is recommended for high-risk patients, including those with prior allergic reactions or a history of anaphylactic reactions. Emergency protocols should be in place to manage any unexpected severe reactions, ensuring patient safety during MRI procedures.
